Why the study?
Does LPS treatment promote CB3-induced autoimmune myocarditis in genetically resistant B10.A mice?
Population
B10.A mice (a strain normally resistant to Coxsackie virus B3-induced autoimmune myocarditis)
Comparison
Coxsackie virus B3 infection combined with… vs Mice infected only with CB3 or treated only with…
Design
Preclinical
Follow-up
14 days
Authors
Loading...
Suggests LPS overcomes genetic resistance in murine myocarditis models; leaves open cytokine/MHC roles in human susceptibility.
Does LPS treatment promote CB3-induced autoimmune myocarditis in genetically resistant B10.A mice?
LPS treatment overcomes genetic resistance to CB3-induced autoimmune myocarditis in B10.A mice, suggesting a role for cytokines and MHC expression in disease susceptibility.
Lane et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: